TEVA - Teva- Pharmaceutical Industries Ltd ADR Dividends

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: VTRS RDY BHC PRGO AMPH OGN HROW COLL SLNO ALKS

| Held by: IEFA EFA EIS EFV IXUS SPDW WCMI IDEV FNDF PPH

Scroll to Statements

Index	-	P/E	26.55	EPS (ttm)	1.35	Insider Own	0.01%	Shs Outstand	1.16B	Perf Week	2.23%
Market Cap	41.61B	Forward P/E	11.52	EPS next Y	3.10	Insider Trans	-95.84%	Shs Float	1.16B	Perf Month	15.41%
Enterprise Value	54.78B	PEG	2.12	EPS next Q	0.60	Inst Own	63.02%	Short Float	2.55%	Perf Quarter	3.00%
Income	1.57B	P/S	2.37	EPS this Y	-21.33%	Inst Trans	0.57%	Short Ratio	4.31	Perf Half Y	45.24%
Sales	17.53B	P/B	5.05	EPS next Y	34.50%	ROA	4.01%	Short Interest	29.74M	Perf YTD	14.48%
Book/sh	7.07	P/C	11.12	EPS next 5Y	5.43%	ROE	21.73%	52W High	37.35 -4.32%	Perf Year	97.73%
Cash/sh	3.21	P/FCF	93.68	EPS past 3/5Y	- -	ROIC	6.99%	52W Low	14.99 138.36%	Perf 3Y	294.37%
Dividend Est.	-	EV/EBITDA	10.79	Sales past 3/5Y	5.53% 0.80%	Gross Margin	52.19%	Volatility	2.85% 2.87%	Perf 5Y	243.56%
Dividend TTM	-	EV/Sales	3.13	EPS Y/Y TTM	220.46%	Oper. Margin	23.22%	ATR (14)	1.11	Perf 10Y	-28.92%
Dividend Ex-Date	Nov 27, 2017	Quick Ratio	0.78	Sales Y/Y TTM	5.76%	Profit Margin	8.98%	RSI (14)	68.07	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	1.01	EPS Q/Q	69.90%	SMA20	7.92%	Beta	0.86	Target Price	42.11
Payout	0.00%	Debt/Eq	2.05	Sales Q/Q	3.60%	SMA50	13.60%	Rel Volume	1.19	Prev Close	36.01
Employees	33346	LT Debt/Eq	1.74	Earnings	Apr 29 BMO	SMA200	35.51%	Avg Volume	6.89M	Price	35.73
IPO	Feb 16, 1982	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.53% 5.14%	Trades		Volume	8,220,001	Change	-0.78%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)